All lesions | High-grade glioma | Brain metastasis | |
---|---|---|---|
Number of RT courses in the area of RID | |||
1 | 17 (50.0%) | 14 (77.8%) | 3 (18.8%) |
2 | 15 (44.1%) | 4 (22.2%) | 11 (68.8%) |
3 | 2 (5.9%) | 0 (0.0%) | 2 (12.5%) |
Median cumulative EQD22 in Gy excluding boost (IQR) | 103.2 (60.0–176.3) | 60.0 (55.6–70.3) | 162.4 (121.8–235.6) |
Median cumulative BED2 in Gy excluding boost (IQR) | 206.4 (120.0–352.5) | 120.0 (111.3–140.6) | 324.8 (243.6–471.3) |
Number of cases that received hypofractionation (single dose ≥2.5 Gy) in at least one RT course | 20 (58.8%) | 4 (22.2%) | 16 (100.0%) |
Median single RT course EQD22 in Gy excluding boost (IQR) | 60.0 (55.2–90.0) | 60.0 (53.3–60.0) | 71.6 (60.0–120.8) |
Median number of fractions per single RT course (IQR) | 11 (1–30) | 30 (29.3–30.8) | 3 (1–11) |
Fractions per day (single RT course) | |||
3/week | 1 (1.9%) | 0 (0.0%) | 1 (3.2%) |
1/day | 48 (90.6%) | 19 (86.4%) | 29 (93.5%) |
2/day | 4 (7.5%) | 3 (13.6%) | 1 (3.2%) |
Median prescription dose (single RT course) in Gy (IQR) | 41.8 (24.0–59.2) | 59.4 (53.3–60.0) | 25.6 (21.0–41.8) |
Median single fraction dose in Gy (IQR) | 3.8 (2.0–18.0) | 2.0 (1.8–2.0) | 8.0 (3.8–21.0) |
Median maximum dose within PTV (single RT course) in Gy (IQR) | 43.4 (30.0–63.6) | 64.1 (56.1–68.3) | 30.0 (26.5–43.3) |
Median PTV volume in ccm excluding WBRT (IQR)* | 15.9 (4.2–196.0) | 203.9 (155.1–308.9) | 6.7 (3.2–14.2) |
Median coverage of RID lesion by single RT course PTV in percent (IQR) | 82.1 (42.9–99.8) | 97.8 (91.8–100.0) | 46.4 (39.2–82.1) |
Median coverage of RID lesion by combined PTV in percent (IQR) | 97.8 (88.1–100.0) | 99.9 (96.7–100.0) | 89.8 (52.9–99.7) |
Number of RTs with boost | 13 (24.5%) | 12 (54.5%) | 1 (3.2%) |
Median boost volume in ccm (IQR) | 14.8 (7.8–72.9) | 16.6 (8.8–78.2) | 0.2 (n = 1) |
Median boost EQD22 in Gy (IQR) | 69.3 (67.7–71.7) | 69.3 (66.8–71.1) | 90.6 (n = 1) |
Prescription isodose line | |||
70% 80% 95% | 11 (20.8%) 16 (30.2%) 26 (49.1%) | 1 (4.5%) 1 (4.5%) 20 (90.9%) | 10 (32.3%) 15 (48.4%) 6 (19.4%) |